Long-Term Effect of Pancreaticoduodenectomy Combined with Revascularization for Resectable Pancreatic Carcinoma in Elderly Patients

Jiali Yang; Zhengrong Xu; Junfeng Zhang; Yao Zheng; Jianyou Gu; Qiang Zhou; Xianxing Wang; Shixiang Guo; Hongyu Zhang; Shengkai Chen; Huaizhi Wang

doi:10.12659/MSM.938443

21 November 2022: Clinical Research

Long-Term Effect of Pancreaticoduodenectomy Combined with Revascularization for Resectable Pancreatic Carcinoma in Elderly Patients

Jiali Yang ^1ABCDEF* , Zhengrong Xu ^2ABCD* , Junfeng Zhang ^1CD , Yao Zheng ^1CD , Jianyou Gu ^1AC , Qiang Zhou ^1CD , Xianxing Wang ^1CD , Shixiang Guo ^1DF , Hongyu Zhang ^3AD , Shengkai Chen ^1ADG* , Huaizhi Wang ^1ADG*

DOI: 10.12659/MSM.938443

Med Sci Monit 2022; 28:e938443

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Figure 1 Kaplan-Meier estimates of OS and PFS for the 3 age group patients of PDAC treated with PDR: (A, B) shows the age-related OS and PFS for all patients, (C, D) shows the age-related OS and PFS for patients of PDAC with SMV invasion.

Back to the Article

Long-Term Effect of Pancreaticoduodenectomy Combined with Revascularization for Resectable Pancreatic Carcinoma in Elderly Patients

Your Privacy